The Need for Standardized Guidelines for the Use of Monocyte Distribution Width (MDW) in the Early Diagnosis of Sepsis DOI Open Access
Andrea Piccioni,

Fabio Spagnuolo,

Silvia Baroni

и другие.

Journal of Personalized Medicine, Год журнала: 2024, Номер 15(1), С. 5 - 5

Опубликована: Дек. 27, 2024

Sepsis is a complex and potentially life-threatening syndrome characterized by an abnormal immune response to infection, which can lead organ dysfunction, septic shock, death. Early diagnosis crucial improving prognosis reducing hospital management costs. This narrative review aims summarize evaluate the current literature on role of monocyte distribution width (MDW) as diagnostic biomarker for sepsis, highlighting its advantages, limitations, potential clinical applications. MDW measures volumetric monocytes, reflecting monocytic anisocytosis, detected using advanced hematological analyzers. In 2019, it was approved FDA sepsis due ability identify systemic inflammatory at early stage. Thirty-one studies analyzed us have shown that increased value associated with higher risk combination parameters (such qSOFA) other biomarkers (CRP, PCT) enhance sensitivity stratification capacity. Despite high sensitivity, has lower specificity compared more established such procalcitonin, thus requiring multimodal integration accurate diagnosis. The use in emergency intensive care settings represents opportunity improve critical patient management, particularly when combined markers tools. However, further are needed define universal cut-off confirm validity different contexts pathological scenarios.

Язык: Английский

The Role of Monocyte Distribution Width (MDW) in the Prediction of Death in Adult Patients with Sepsis DOI Creative Commons
Dimitrios Theodoridis, Angeliki Tsifi, Emmanouil Magiorkinis

и другие.

Microorganisms, Год журнала: 2025, Номер 13(2), С. 427 - 427

Опубликована: Фев. 15, 2025

Sepsis is a life-threatening condition; it major cause of hospital mortality worldwide and constitutes global health problem. This research investigates the use MDW as predictor for septic patients. was double-center prospective cohort study adult Septic patients were identified categorized into two categories: those who improved died. Blood drawn from three times, on first, third, fifth day their admission to hospital. evaluated biomarker predict patient outcome. In addition, existing inflammatory markers recorded in all The able patient's average found be significantly higher died records. For example, an value 28.4 first shown best cut-off determining fatal outcomes; receiver operating characteristic (ROC) analysis revealed area under curve 0.71 (95% Confidence Interval-CI: 0.57-0.84) with sensitivity 64.7% specificity 88.2%. conclusion, MDW, addition being marker that can quickly detect sepsis more effectively than other biomarkers, which proven by numerous studies, could also used indicator work attempt direction.

Язык: Английский

Процитировано

0

Monocyte distribution width as an early predictor of short-term outcome in adult patients with sepsis DOI
Yin Liu, Ruizhi Wang,

Shihua Zhong

и другие.

Clinical Chemistry and Laboratory Medicine (CCLM), Год журнала: 2023, Номер 62(3), С. 562 - 571

Опубликована: Окт. 10, 2023

Monocyte distribution width (MDW) is a quantitative measurement of monocyte anisocytosis and has been proposed as an efficient marker for early sepsis detection. This study aimed to assess the prognostic potential MDW in septic patients.

Язык: Английский

Процитировано

8

The Need for Standardized Guidelines for the Use of Monocyte Distribution Width (MDW) in the Early Diagnosis of Sepsis DOI Open Access
Andrea Piccioni,

Fabio Spagnuolo,

Silvia Baroni

и другие.

Journal of Personalized Medicine, Год журнала: 2024, Номер 15(1), С. 5 - 5

Опубликована: Дек. 27, 2024

Sepsis is a complex and potentially life-threatening syndrome characterized by an abnormal immune response to infection, which can lead organ dysfunction, septic shock, death. Early diagnosis crucial improving prognosis reducing hospital management costs. This narrative review aims summarize evaluate the current literature on role of monocyte distribution width (MDW) as diagnostic biomarker for sepsis, highlighting its advantages, limitations, potential clinical applications. MDW measures volumetric monocytes, reflecting monocytic anisocytosis, detected using advanced hematological analyzers. In 2019, it was approved FDA sepsis due ability identify systemic inflammatory at early stage. Thirty-one studies analyzed us have shown that increased value associated with higher risk combination parameters (such qSOFA) other biomarkers (CRP, PCT) enhance sensitivity stratification capacity. Despite high sensitivity, has lower specificity compared more established such procalcitonin, thus requiring multimodal integration accurate diagnosis. The use in emergency intensive care settings represents opportunity improve critical patient management, particularly when combined markers tools. However, further are needed define universal cut-off confirm validity different contexts pathological scenarios.

Язык: Английский

Процитировано

0